Gene mutations in acute myeloid leukemia.

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Acute Myeloid Leukemia (AML) is a complex disease characterized by diverse chromosomal abnormalities and gene mutations.
• Recent advancements in next-generation sequencing have significantly expanded the understanding of AML-related gene mutations and clonal evolution in relapse.

Purpose of the Study:

• To outline recent findings on gene mutations in Acute Myeloid Leukemia (AML).
• To highlight the role of gene mutations as prognostic factors and targets for molecular therapies.

Main Methods:

• Review of recent scientific literature and findings on gene mutations in AML.
• Analysis of next-generation sequencing data to identify AML-related gene mutations and their impact on clonal evolution.

Main Results:

• Epigenetic regulatory gene mutations are identified in pre-leukemic cells.
• Acquisition of multiple genetic mutations is strongly associated with AML onset and clonal diversity.
• Specific mutations like FLT3, IDH, NPM1, and CEBPA are recognized as prognostic factors and therapeutic targets.

Conclusions:

• Gene mutations in AML are pivotal for understanding disease pathogenesis, prognosis, and treatment strategies.
• Targeted therapies, such as FLT3 and IDH inhibitors, show promise in AML treatment.
• Prognostic classifications increasingly incorporate specific gene mutations alongside chromosomal aberrations.